![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...
Regulatory News: GeNeuro SA (Paris:GNRO) and GILBERT DUPONT have terminated the liquidity contract entered into on March 6, 2021. This termination took effect on June 30, 2024, after market...
Market: Euronext Paris ISIN code / Mnemo: CH0308403085 / GNRO Web site: www.geneuro.com Regulatory News: Pursuant to the liquidity contract entrusted by GENEURO SA (Paris:GNRO) to Gilbert Dupont...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 – GNRO): L'essai clinique GNC-501 est une étude de phase 2 chez des patients souffrant de syndromes neuropsychiatriques post-COVID-19...
81,54% du capital social de la société était représenté à l'assemblée générale et les résolutions ont toutes été approuvées à l’unanimité Regulatory News: GeNeuro (Euronext Paris : CH0308403085...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0178 | 28.7096774194 | 0.062 | 0.0876 | 0.062 | 33928 | 0.07791029 | DE |
4 | 0.0198 | 33 | 0.06 | 0.0876 | 0.06 | 33072 | 0.07191291 | DE |
12 | -1.8702 | -95.9076923077 | 1.95 | 2.35 | 0.0558 | 109177 | 0.23938581 | DE |
26 | -1.2602 | -94.0447761194 | 1.34 | 2.35 | 0.0558 | 54238 | 0.3679822 | DE |
52 | -1.4952 | -94.9333333333 | 1.575 | 2.35 | 0.0558 | 31044 | 0.50254398 | DE |
156 | -3.8302 | -97.9590792839 | 3.91 | 4.24 | 0.0558 | 13426 | 1.05496858 | DE |
260 | -3.3202 | -97.6529411765 | 3.4 | 6.28 | 0.0558 | 10621 | 1.73020941 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions